Skip to main content
Contact Us
Subscribe
E-Edition
84°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunocore Holdings Plc ADR
(NQ:
IMCR
)
57.80
-0.20 (-0.34%)
Streaming Delayed Price
Updated: 3:15 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunocore Holdings Plc ADR
< Previous
1
2
3
4
5
Next >
Immunocore Reveals First Data From HIV Infection Candidate Study
February 22, 2023
Via
Benzinga
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
February 22, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
February 13, 2023
Immunocore is the IBD Stock of the Day as the biotech company expands its pipeline. Earnings For IMCR stock are due in March.
Via
Investor's Business Daily
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
Analyst Ratings for Immunocore Hldgs
November 30, 2022
Via
Benzinga
Where Immunocore Hldgs Stands With Analysts
November 30, 2022
Via
Benzinga
7 Analysts Have This to Say About Immunocore Hldgs
November 30, 2022
Via
Benzinga
Where Immunocore Hldgs Stands With Analysts
November 10, 2022
Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings within the last quarter:
Via
Benzinga
What 6 Analyst Ratings Have To Say About Immunocore Hldgs
October 13, 2022
Analysts have provided the following ratings for Immunocore Hldgs (NASDAQ:IMCR) within the last quarter:
Via
Benzinga
Immunocore to present at upcoming investor conferences
February 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
3 Pharma Stocks That Will Mint Millionaires
January 30, 2023
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters.
Via
InvestorPlace
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
January 09, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
5 Analysts Have This to Say About Immunocore Hldgs
September 14, 2022
Within the last quarter, Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
Via
Benzinga
Immunocore is awarded the Prix Galien France award for KIMMTRAK
December 15, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
December 08, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
December 02, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
November 30, 2022
Via
Benzinga
Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference
November 23, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
During Monday's session, 50 stocks hit new 52-week highs.
Via
Benzinga
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday
November 21, 2022
Via
Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
November 18, 2022
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
Via
Benzinga
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
November 11, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
November 11, 2022
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.
Via
MarketBeat
Immunocore to present at the Jefferies London Healthcare Conference
November 10, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Via
Benzinga
Dow Climbs More Than 400 Points, S&P 500 Rises 1.5%
September 09, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday.
Via
Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
September 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.